Data is not available at this time.
Nomura Micro Science Co., Ltd. is a specialized provider of advanced water treatment technologies, serving industries such as electronics, pharmaceuticals, biotechnology, and food production. The company designs, installs, and sells a comprehensive range of water treatment systems, including ultra-pure water production, wastewater treatment, and water reclamation solutions. Its product portfolio spans filtration, ion exchange, reverse osmosis, and monitoring systems, tailored to high-purity requirements in critical manufacturing processes. Operating primarily in Japan, South Korea, Taiwan, China, and the U.S., Nomura Micro Science has established itself as a trusted partner for industries demanding stringent water quality standards. The company’s expertise in pharmaceutical-grade water systems and semiconductor-grade ultra-pure water positions it as a niche leader in high-value industrial applications. Its integrated services, including water analysis and on-site supply, further enhance its value proposition in a market increasingly focused on sustainability and regulatory compliance. With a foundation dating back to 1969, the firm combines deep technical knowledge with long-term client relationships, reinforcing its competitive edge in a sector where reliability and precision are paramount.
Nomura Micro Science reported revenue of JPY 73.0 billion for FY 2024, with net income of JPY 7.98 billion, reflecting a robust net margin of approximately 10.9%. The company’s diluted EPS stood at JPY 209.7, demonstrating strong earnings generation. However, operating cash flow was negative at JPY -18.7 billion, likely due to working capital adjustments or project timing, while capital expenditures remained modest at JPY -356 million, indicating efficient asset utilization.
The company’s earnings power is underscored by its JPY 7.98 billion net income, supported by its specialized market positioning. Capital efficiency appears balanced, with limited capex relative to revenue, suggesting a lean operational model. The negative operating cash flow warrants monitoring, but the firm’s profitability metrics remain healthy, with ROE likely elevated given its net income and equity base.
Nomura Micro Science holds JPY 12.1 billion in cash and equivalents against total debt of JPY 22.4 billion, indicating a manageable leverage position. The balance sheet reflects a focus on growth financing, with liquidity sufficient to cover near-term obligations. The debt level is moderate relative to its JPY 76.9 billion market cap, suggesting financial flexibility for strategic investments or cyclical downturns.
The company’s growth is tied to demand for high-purity water systems in electronics and pharmaceuticals, sectors with steady expansion. Its dividend payout of JPY 80 per share signals a commitment to shareholder returns, with a yield likely competitive within its peer group. Future growth may hinge on geographic expansion and technological advancements in water treatment, particularly in emerging markets.
With a market cap of JPY 76.9 billion and a beta of 1.4, Nomura Micro Science trades with higher volatility than the broader market, reflecting its niche focus. Investors likely price in its expertise in high-margin water treatment solutions, though the negative operating cash flow may temper valuation multiples until clarity on cash conversion improves.
Nomura Micro Science’s deep industry expertise and diversified client base provide resilience against sector-specific downturns. Its focus on high-growth areas like semiconductor and pharmaceutical water systems positions it well for long-term demand. Challenges include managing working capital cycles and expanding in competitive international markets, but its technical differentiation and established reputation offer a solid foundation for sustained performance.
Company description, financial data from disclosed filings, and market data from exchange sources.
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |